Answers are grounded in this paper and cite their sources.
Exploratory study identifies bioactive flavonoids and vitamin D2 precursors in Evernia prunastri, suggesting therapeutic potential.
This study aimed to explore Evernia prunastri, lichen potential as a source of bioactive flavonoids and natural precursors of vitamin D2. Extracts obtained by maceration and Soxhlet were subjected to phytochemical analysis, revealing a high content of total phenolics (25.5 mg GAE/100 g) and total flavonoids (0.285 mg QE/g). Antioxidant, anti-inflammatory and antibacterial activities were evaluated using in-vitro assays. Antioxidant potency, measured by DPPH assay, revealed IC₅₀ of 0.049 mg/mL, indicating notable activity. Inhibition of protein denaturation (indicator of anti-inflammatory activity), showed IC₅₀ of 388.52 μg/mL. The extracts also had moderate antibacterial activity against Escherichia coli and Pseudomonas aeruginosa. Finally, the detection of ergosterol a fungal sterol characteristic of lichens and a precursor of vitamin D₂ (ergocalciferol) by gas chromatography-mass spectrometry (GC/MS) confirmed the nutraceutical activity of this specie. This plant-based form of vitamin D is distinct from animal-derived vitamin D₃ (cholecalciferol), derived from 7-dehydrocholesterol. These results showed Evernia prunastri as a promising source of bioactive compounds with therapeutic and nutritional potential.
No takes yet. Share an insight, caveat, or question.
Mokrane*1 et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: